What is Acadia Pharmaceuticals's revenue?

Acadia Pharmaceuticals (ACAD) generated $1.1B in revenue over the trailing twelve months, up 9.9% year over year.

Is Acadia Pharmaceuticals profitable?

Acadia Pharmaceuticals reported $375.7M in net income over the trailing twelve months, a 34.3% net margin.

What are Acadia Pharmaceuticals's profit margins?

Gross margin is 91.5% and operating margin is 7.4%, with a 34.3% net margin.

What is Acadia Pharmaceuticals's earnings per share?

Acadia Pharmaceuticals's diluted EPS over the trailing twelve months is $2.21.

Where does Acadia Pharmaceuticals's income statement data come from?

Every line is extracted from Acadia Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Acadia Pharmaceuticals ACAD Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Total revenue	$268.06M-5.6%	$283.99M+1.9%	$278.63M+5.3%	$264.57M+8.3%	$244.32M-5.9%
Total cost of revenue	$24.79M-5.5%	$26.23M+21.1%	$21.65M+4.4%	$20.73M+1.7%	$20.39M-6.5%
Gross profit	$243.27M-5.6%	$257.76M+0.3%	$256.99M+5.4%	$243.83M+8.9%	$223.93M-5.8%
Gross margin	90.8%0.0pp	90.8%-1.5pp	92.2%+0.1pp	92.2%+0.5pp	91.7%+0.1pp
Research and development	$76.87M-9.3%	$84.76M-3.5%	$87.83M+12.7%	$77.95M-0.4%	$78.27M-22.3%
Selling, general and administrative	$171.02M+9.9%	$155.62M+16.7%	$133.4M-0.1%	$133.51M+5.6%	$126.37M-2.9%
Total costs & expenses	$272.68M+2.3%	$266.6M+9.8%	$242.88M+4.6%	$232.19M+3.2%	$225.03M+112%
Operating income	-$4.62M-127%	$17.39M-51.4%	$35.76M+10.4%	$32.37M+67.8%	$19.29M-87.4%
Operating margin	-1.7%-7.8pp	6.1%-6.7pp	12.8%+0.6pp	12.2%+4.3pp	7.9%-51.2pp
Interest expense	$8.06M-3.3%	$8.33M+1.0%	$8.25M+13.8%	$7.24M-8.3%	$7.9M+12.8%
Other income (expense), net	$542K-9.1%	$596K+0.5%	$593K-0.2%	$594K+1.0%	$588K+2.3%
Income before income taxes	$3.98M-84.9%	$26.32M-41.0%	$44.6M+10.9%	$40.21M+44.8%	$27.78M-82.8%
Income tax expense	$344K+100%	-$247.25M-810%	-$27.18M-301%	$13.55M+54.1%	$8.79M-49.3%
Net income	$3.64M-98.7%	$273.57M+281%	$71.78M+169%	$26.67M+40.4%	$18.99M-86.8%
Net margin	1.4%-95.0pp	96.3%+70.6pp	25.8%+15.7pp	10.1%+2.3pp	7.8%-47.6pp
Diluted earnings per share	$0.02-98.8%	$1.61+283%	$0.42+163%	$0.16+45.5%	$0.11-87.2%
EBITDA	-$1.62M-108%	$20.32M-47.5%	$38.71M+9.6%	$35.31M+58.8%	$22.24M-86.0%
EBITDA margin	-0.6%-7.8pp	7.2%-6.7pp	13.9%+0.5pp	13.3%+4.2pp	9.1%-52.0pp
EBIT	-$4.62M-127%	$17.39M-51.4%	$35.76M+10.4%	$32.37M+67.8%	$19.29M-87.4%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Acadia Pharmaceuticals.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Acadia Pharmaceuticals's revenue?: Acadia Pharmaceuticals (ACAD) generated $1.1B in revenue over the trailing twelve months, up 9.9% year over year.
Is Acadia Pharmaceuticals profitable?: Acadia Pharmaceuticals reported $375.7M in net income over the trailing twelve months, a 34.3% net margin.
What are Acadia Pharmaceuticals's profit margins?: Gross margin is 91.5% and operating margin is 7.4%, with a 34.3% net margin.
What is Acadia Pharmaceuticals's earnings per share?: Acadia Pharmaceuticals's diluted EPS over the trailing twelve months is $2.21.
Where does Acadia Pharmaceuticals's income statement data come from?: Every line is extracted from Acadia Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.